Lawyer profile
Amy Speros
Latham & Watkins LLP
- Firm
- Latham & Watkins LLP
- Practice
- FDA regulatory, healthcare regulatory, life sciences regulatory
- Office
- San Diego, Washington, D.C.
- Active in the record
- 2020 to 2026
Deal experience
Jurisdictions
Deals
7 announced deals in the record Latham & Watkins Advises on Vaderis Therapeutics’ US$152 Million Series B Financing 24 Sept 2026
Latham & Watkins Advises IDEAYA Biosciences on US$300 Million Offering of Common Stock and Pre‑Funded Warrants 11 Jun 2026
Latham & Watkins Advises on Medline’s Upsized Landmark US$7.2 Billion IPO 19 Dec 2025
Latham & Watkins Advises IDEAYA Biosciences in Public Offering 2 Nov 2023
Latham & Watkins Advises IDEAYA Biosciences in Pricing of Public Offering 26 Apr 2023
Latham & Watkins Advises Skinbetter Science in Acquisition by L’Oréal 18 Oct 2022
Latham Advises Aligos Therapeutics in its IPO 16 Oct 2020
Deal alerts PRO
Get an email when Amy Speros is named on a newly announced deal.
Alerts come as one daily email at most.
Analytics
Based on announced deals in DealDatabaseLoading analytics…
Complete deal history
Is this you?
Claim your profile to add your title, a biography and a photo, and show a verified badge. It is free.
Claim this profile